Optimising Diagnosis and Management of Patients with Oncogene-Addicted Localised Non-small Cell Lung Cancer

Start date

26 Mar 2025

End date

26 Mar 2025

Location

Room N02

Starts on

26 Mar 2025 at 12:20 CET

Add to Calendar 26-03-2025 12:30 26-03-2025 13:30 Europe/Paris Optimising Diagnosis and Management of Patients with Oncogene-Addicted Localised Non-small Cell Lung Cancer
More info on: https://www.esmo.org/meeting-calendar/european-lung-cancer-congress-2025/esmo-colloquia/optimising-diagnosis-and-management-of-patients-with-oncogene-addicted-localised-non-small-cell-lung-cancer Room N02

Programme

• 26 March 2025

12:20

Welcome and introduction

Pilar Garrido Lopez, Madrid, Spain

12:23

Clinical case of localised NSCLC relapsing with oncogene-addicted metastases and analysis of real-world biomarker testing strategies

Mariana Brandão, Brussels, Belgium

12:35

How to optimise the science and workflows for biomarker testing in localised NSCLC: Tissue and plasma

Frédérique Penault-Llorca, Clermont-Ferrand, France

12:47

State-of-the-art biomarker-driven management of patients with oncogene-addicted localised NSCLC

Pilar Garrido Lopez, Madrid, Spain

12:59

Ongoing clinical research activity for patients with localised oncogene-addicted NSCLC

Fabrice Barlesi, Villejuif, France

13:11

Q&A and discussion

All speakers

13:18

Concluding remarks

Mariana Brandão, Brussels, Belgium

Learning objectives

• To be informed on current real-world practices and optimal workflows for biomarker testing in localised NSCLC
• To be provided an update on state-of-the-art management of patients with localised oncogene-addicted NSCLC
• To obtain expert insights on ongoing clinical research in localised NSCLC